Clinical Trial Update: Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intraperitoneal docetaxel in combination with the mFOLFOX6 regimen for gastric cancer patients with peritoneal carcinomatosis; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Leucovorin calcium (calcium folinate)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Peritoneal Carcinomatosis | Phase 1 | Status: TERMINATED